BOSTON, May 9, 2013 /PRNewswire/ -- Just in time for Mother's Day, Ovuline – the first health IT company to bring big data and machine learning to the fertility and pregnancy space – is launching a new version of its Smart Fertility™ product to help women conceive faster.
With 7.3 million people struggling with infertility this Mother's Day, Ovuline's new product addresses an issue that hits home for couples all over the world. By using a combination of big data, machine learning and mobile health tracking devices, Ovuline's new Smart Fertility™ product understands a woman's unique cycle and predicts when she is most fertile.
"Many women don't realize that the process of getting pregnant can take much longer than expected, especially if they have an irregular cycle and don't ovulate at the same time each month," said Paris Wallace, CEO of Ovuline. "The challenge is pinpointing the days when a woman is most fertile. Until now, women relied on outdated one-size-fits all content and basic mathematical equations to make this prediction. But we have developed a way to use unique, real-time data and technology to drive our proprietary Prediction Engine and provide each Ovuline user with their own personalized results."
Smart Fertility™ is the only quantified-self (or "self-tracking") app and web-based service for fertility. Since its beta launch in September 2012, Ovuline has helped more than 50,000 women trying to get pregnant. The company is now officially launching its Smart Fertility™ product, which uses advanced technology based on more than 2.5 million data points from women across the globe.
In addition to developing a smarter, more accurate "Prediction Engine" for fertility, Ovuline has also incorporated new features into the product:
- Interactive timeline where women can view their personal data
- Real-time feedback on a woman's unique cycle and lifestyle information
- Personalized health plan, delivered daily from Ovuline
- Integration with quantified self devices, including FitBit and Withings
Women can take control of their own fertility process with Ovuline by signing up, creating a profile and entering their health data points, including lifestyle elements such as sleep, activity and diet, on a daily basis. The company offers solutions at various price points, all of which are less than $50.
"We also see ourselves as a resource that empowers and educates women about fertility," added Wallace. "Many women who experience difficulties getting pregnant immediately blame themselves, when in fact they don't realize basic facts about the ovulation process that would alleviate those concerns. We provide daily, actionable advice that women can follow so that they feel they're being proactive about their pregnancy."
In addition to its Smart Fertility™ product, Ovuline will roll out its Pregnancy Tracker app towards the end of 2013. Ovuline's Pregnancy Tracker was developed with the help of pregnancy and wellness experts, as well as moms across the United Sates. Similar to Smart Fertility™, the Pregnancy Tracker combines women's health data from wearable health tracking devices and mobile technology to continuously monitor a woman's key pregnancy health indicators and alert women if they have an acute health risk. It will also provide personalized advice on how to have a healthier pregnancy based on analysis of their unique data.
To sign up for a beta test of Ovuline's Pregnancy Tracker, please visit http://ovuline.com/smart-pregnancy.
Ovuline is the first health IT company to bring big data and machine learning to the fertility and pregnancy space, helping couples get pregnant faster and have healthier pregnancies. By using a combination of big data, machine learning and mobile health tracking devices, Ovuline's new Smart Fertility™ product understands a woman's unique cycle and predicts when she is most fertile. Ovuline's Smart Fertility™ and Pregnancy Tracker products were developed with the help of Harvard scientists, fertility experts and moms across the country. The company completed Boston Techstars in November 2012 and is venture-backed by Lightbank, LionBird, Launch Capital and Techstars founder and CEO David Cohen. For more information, visit http://ovuline.com.
Twitter: @ovuline | FB: facebook.com/Ovuline